CMB International Private Investment Limited sold 1.15 million shares of BIOCYTOGEN-B stock at an average of HKD 54.6372 per share on September 1, 2026, involving HKD 62.75 million.
Prior to the disposal, CMB International Private Investment Limited's long position in BIOCYTOGEN-B was 12.13 million shares, representing 10.95%; following the disposal, the holding changed to 10.98 million shares, with the long position ratio falling to 9.91%.